We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Innovative Technique Diagnoses Intestinal Parasitic Infections

By LabMedica International staff writers
Posted on 12 Aug 2013
A recently developed method for directly diagnosing intestinal parasites has been evaluated in the field and compared with standard methodology. More...


Soil-transmitted helminthes and intestinal protozoa infection are widespread in developing countries, yet an accurate diagnosis is rarely performed as the highly trained laboratory scientists required are seldom available in poor resource settings.

Microbiologists at the San Raffaele Hospital (Milan, Italy) in collaboration with others, analyzed stool samples from 180 pupils from two primary schools in India and Tanzania. Three diagnostic methods were used: direct fecal smear, formol-ether concentration method (FECM) and mini-FLOTAC. The latter is a simplified device and one of the main advantages of this method is that it can be more easily transferred and carried out in laboratories with limited facilities as there is no centrifugation required. The mini-FLOTAC comprises two physical components, the base and the reading disc. There are two 1-mL flotation chambers, which are designed for optimal examination of fecal sample suspensions in each flotation chamber and which permits a maximum magnification of ×400.

Overall, 72% of the pupils were positive for any intestinal parasitic infection, 24% carried dual infections, and 11% had three infections or more. The most frequently encountered intestinal parasites were Entamoeba coli, Entamoeba histolytica/dispar, Giardia intestinalis, hookworm, and Schistosoma mansoni in Tanzania. Significant differences were found in the detection of parasitic infections among the three methods. The mini-FLOTAC was the most sensitive method for helminthic infections at 90%, for the FECM provided 60% detection, and only 30% for the direct fecal smear. However, the FECM was the most sensitive for intestinal protozoa infections at 88% with 70% for direct fecal smear, and 68% for the mini-FLOTAC.

The authors concluded that the mini-FLOTAC for the diagnosis of intestinal helminthes and protozoa is a valid, sensitive, and potentially low-cost alternative technique that could be used in resource-limited settings, particularly for helminthic diagnosis. The mini-FLOTAC and fill-FLOTAC were invented and patented by Prof. Giuseppe Cringoli (University of Naples Federico II, Italy).

Related Links:

San Raffaele Hospital
University of Naples Federico II



Gold Member
Nucleic Acid Extractor System
NEOS-96 XT
Online QC Software
Acusera 24•7
New
Automated Urinalysis Solution
UN-9000
New
HPV Test
Allplex HPV28 Detection
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Originally designed for lung cancer detection and resistance monitoring, the test also shows potential for identifying signals linked to pulmonary fibrosis (image credit: iStock)

Urine-Based Nanosensor Tracks Lung Cancer and Fibrosis Noninvasively

Lung cancer remains difficult to monitor for early progression and treatment resistance, while pulmonary fibrosis continues to pose major challenges for early diagnosis. Clinicians need repeatable, noninvasive... Read more

Molecular Diagnostics

view channel
Image: Researchers found that tumor DNA fragments in blood can reveal ongoing prostate cancer growth even when current tests show little change (image credit: Adobe Stock)

Blood Test Detects Early Nonresponse in Metastatic Prostate Cancer

Prostate cancer is the most common cancer in the U.K., with more than 64,000 men diagnosed and 12,000 deaths each year. For the roughly 10,000 men annually with advanced disease, early assessment of treatment... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.